汪忠鎬 1,2 , 李震 2
  • 1.首都醫(yī)科大學宣武醫(yī)院血管外科(北京100053);;
  • 2.第二炮兵總醫(yī)院心胸血管外科中心(北京100088);

我國血管外科在布加綜合征的研究和治療、血管腔內(nèi)技術(shù)、人工血管內(nèi)皮化、干細胞移植治療肢體缺血等方面均達到國際水平［1，2］?，F(xiàn)就我國血管外科的進展和特點分述如下。......

引用本文： 汪忠鎬,李震. 我國血管外科的現(xiàn)狀和發(fā)展. 中國普外基礎(chǔ)與臨床雜志, 2006, 13(6): 625-628. doi: 復(fù)制

1. 　汪忠鎬. 20世紀血管外科的回顧與21世紀的展望 [J]. 中國實用外科雜志, 2000; 20(1)∶18.
2. 　汪忠鎬. 我國血管外科手術(shù)的過去、 現(xiàn)在和未來 [J]. 中國現(xiàn)代手術(shù)學雜志， 2003； 7(2)∶81.
3. 　汪忠鎬, 陳學明, 余　軍. 支架型人工血管治療主動脈夾層動脈瘤 [J]. 中國普通外科雜志， 1999; 8(6)∶403.
4. 　汪忠鎬, 潭銘勛. 顱外阻塞性腦血管病 [J]. 中華老年醫(yī)學雜志, 1985; 4∶158.
5. 　谷涌泉， 張　建， 郭連瑞， 等. 自體骨髓干細胞移植治療下肢嚴重缺血: 32例報告 [J]. 中國臨床康復(fù), 2004; 8(34)∶7970.
6. 　Wang Z, Shen L, Yu J, et al. Management of cerebral ischemia due to Takayasu’s arteritis [J]. Chin Med J (Engl)， 2002; 115(3)∶342.
7. 　Wang ZG, Zhang FJ, Yi MQ, et al. Evolution of management for Budd-Chiari syndrome: a team’s view from 2 564 patients [J]. ANZ J Surg， 2005; 75(1-2)∶55.
8. 　Wang ZG, Massimo CG, Li M, et al. Deployment of endograft in the ascending aorta to reverse type A aortic dissection [J]. Asian J Surg， 2003; 26(2)∶117.
9. 　Massimo CG, Wang ZG, Cruz Guadron EA, et al. Endoluminal replacement of the entire aorta for acute type A aortic dissection in a patient with Marfan syndrome [J]. J Thorac Cardiovasc Surg， 2000; 120(4)∶818.
10. 　Wang ZG. Treating disorders in the great vessels with minimally invasive approaches [J]. International Angiology， 2004; 23 (Suppl 1)∶92.
11. 　汪忠鎬， 李　鳴， 谷涌泉， 等. 主動脈減速傷的治療(附12例報告) [J]. 腹部外科， 2004； 17(2)∶81.
12. 　Wang ZG, Li C. Single-branch endograft for treating stanford type B aortic dissections with entry tears in proximity to the left subclavian artery [J]. J Endovasc Ther， 2005; 12(5)∶588.
13. 　Wang ZG. Development of endovascular technology in China in recent 20 years [J]. Chin J Clin Rehabilitation， 2005; 9（30）∶1.
14. 　汪忠鎬. 中國血管外科研究20年: 從血管組織工程樣(生物化人工血管)研究到干細胞移植 [J]. 中國臨床康復(fù)， 2005； 9（22）∶89.
15. 　Kim HJ, Jang SY, Park JI, et al. Vascular endothelial growth factor-induced angiogenic gene therapy in patients with peripheral artery disease [J]. Exp Mol Med， 2004; 36(4)∶336.
16. 　Kusumanto YH, Weel VV, Mulder NH, et al. Treatment with intramuscular vascular endothelial growth factor gene compared with placebo for patients with diabetes mellitus and critical limb ischemia: a double-blind randomized trial [J]. Hum Gene Ther， 2006; [Epub ahead of print].
17. 　Tan PH, Chan CL, Chan C, et al. The evolving role of gene-based treatment in surgery [J]. Br J Surg， 2005; 92(12)∶1466.
18. 　Tiera MJ, Winnik FO, Fernandes JC. Synthetic and natural polycations for gene therapy: state of the art and new perspectives [J]. Curr Gene Ther， 2006; 6(1)∶59.
19. 　Li Z, Iwai M, Wu L, et al. Fluvastatin enhances the inhibitory effects of a selective AT1 receptor blocker, valsartan, on atherosclerosis [J]. Hypertension， 2004; 44(5)∶758.
20. 　Iwai M, Chen R, Li Z, et al. Deletion of angiotensin Ⅱ type 2 receptor exaggerated atherosclerosis in apolipoprotein E-null mice [J]. Circulation， 2005; 112(11)∶1636.
21. 　Hunting CB, Noort WA, Zwaginga JJ. Circulating endothelial (progenitor) cells reflect the state of the endothelium: vascular injury, repair and neovascularization [J]. Vox Sang， 2005; 88(1)∶1.
22. 　Wu Y, Zhang J, Gu Y, et al. Expansion of canine bone marrow-derived endothelial progenitor cells and dynamic observation [J]. Ann Vasc Surg， 2006; 20(3)∶387.
23. 　Montalescot G. Present and future developments of antithrombotic agents [J]. Arch Mal Coeur Vaiss， 2006; 99 Spec no.3∶17.
24. 　Cumming ME, Cumming MJ. Endovascular treatment of carotid artery stenosis [J]. J Insur Med， 2005; 37(3)∶214.
25. 　Kougias P, Lin PH, Bush RL, et al. Carotid artery stenting-current status and future directions [J]. Minerva Cardioangiol， 2006; 54(1)∶69.
26. 　Nighoghossian N, Derex L, Douek P. The vulnerable carotid artery plaque: current imaging methods and new perspectives [J]. Stroke， 2005; 36(12)∶2764.
27. 　Laroche D, Delorme S, Anderson T, et al. Computer prediction of balloon angioplasty from artery imaging [J]. Stud Health Technol Inform， 2006; 119∶293.
28. 　McWilliams RG, Fearn SJ, Harris PL, et al. Retrograde fenestration of endoluminal grafts from target vessels: feasibility, technique, and potential usage [J]. J Endovasc Ther， 2003; 10(5)∶946.
29. 　 Linsen MA, Vos AW, Diks J, et al. Fenestrated and branched endografts: assessment of proximal aortic neck fixation [J]. J Endovasc Ther， 2005; 12(6)∶647.
30. 　Kennon RE, Keggi MJ, Keggi KJ. The minimally invasive anterior approach to hip arthroplasty [J]. Orthopade， 2006; [Epub ahead of print].
31. 　Walther T, Falk V, Mohr FW. Minimally invasive surgery for valve disease [J]. Curr Probl Cardiol， 2006; 31(6)∶399.
32. 　Diethrich EB, Ghazoul M, Wheatley GH, et al. Surgical correction of ascending type a thoracic aortic dissection: simultaneous endoluminal exclusion of the arch and distal aorta [J]. J Endovasc Ther， 2005; 12(6)∶660.
33. 　Nio D, Diks J, Linsen MA, et al. Robot-assisted laparoscopic aortobifemoral bypass for aortoiliac occlusive disease: early clinical experience [J]. Eur J Vasc Endovasc Surg， 2005; 29(6)∶586(2006-06-20收稿).
  1. 1. 　汪忠鎬. 20世紀血管外科的回顧與21世紀的展望 [J]. 中國實用外科雜志, 2000; 20(1)∶18.
  2. 2. 　汪忠鎬. 我國血管外科手術(shù)的過去、 現(xiàn)在和未來 [J]. 中國現(xiàn)代手術(shù)學雜志， 2003； 7(2)∶81.
  3. 3. 　汪忠鎬, 陳學明, 余　軍. 支架型人工血管治療主動脈夾層動脈瘤 [J]. 中國普通外科雜志， 1999; 8(6)∶403.
  4. 4. 　汪忠鎬, 潭銘勛. 顱外阻塞性腦血管病 [J]. 中華老年醫(yī)學雜志, 1985; 4∶158.
  5. 5. 　谷涌泉， 張　建， 郭連瑞， 等. 自體骨髓干細胞移植治療下肢嚴重缺血: 32例報告 [J]. 中國臨床康復(fù), 2004; 8(34)∶7970.
  6. 6. 　Wang Z, Shen L, Yu J, et al. Management of cerebral ischemia due to Takayasu’s arteritis [J]. Chin Med J (Engl)， 2002; 115(3)∶342.
  7. 7. 　Wang ZG, Zhang FJ, Yi MQ, et al. Evolution of management for Budd-Chiari syndrome: a team’s view from 2 564 patients [J]. ANZ J Surg， 2005; 75(1-2)∶55.
  8. 8. 　Wang ZG, Massimo CG, Li M, et al. Deployment of endograft in the ascending aorta to reverse type A aortic dissection [J]. Asian J Surg， 2003; 26(2)∶117.
  9. 9. 　Massimo CG, Wang ZG, Cruz Guadron EA, et al. Endoluminal replacement of the entire aorta for acute type A aortic dissection in a patient with Marfan syndrome [J]. J Thorac Cardiovasc Surg， 2000; 120(4)∶818.
  10. 10. 　Wang ZG. Treating disorders in the great vessels with minimally invasive approaches [J]. International Angiology， 2004; 23 (Suppl 1)∶92.
  11. 11. 　汪忠鎬， 李　鳴， 谷涌泉， 等. 主動脈減速傷的治療(附12例報告) [J]. 腹部外科， 2004； 17(2)∶81.
  12. 12. 　Wang ZG, Li C. Single-branch endograft for treating stanford type B aortic dissections with entry tears in proximity to the left subclavian artery [J]. J Endovasc Ther， 2005; 12(5)∶588.
  13. 13. 　Wang ZG. Development of endovascular technology in China in recent 20 years [J]. Chin J Clin Rehabilitation， 2005; 9（30）∶1.
  14. 14. 　汪忠鎬. 中國血管外科研究20年: 從血管組織工程樣(生物化人工血管)研究到干細胞移植 [J]. 中國臨床康復(fù)， 2005； 9（22）∶89.
  15. 15. 　Kim HJ, Jang SY, Park JI, et al. Vascular endothelial growth factor-induced angiogenic gene therapy in patients with peripheral artery disease [J]. Exp Mol Med， 2004; 36(4)∶336.
  16. 16. 　Kusumanto YH, Weel VV, Mulder NH, et al. Treatment with intramuscular vascular endothelial growth factor gene compared with placebo for patients with diabetes mellitus and critical limb ischemia: a double-blind randomized trial [J]. Hum Gene Ther， 2006; [Epub ahead of print].
  17. 17. 　Tan PH, Chan CL, Chan C, et al. The evolving role of gene-based treatment in surgery [J]. Br J Surg， 2005; 92(12)∶1466.
  18. 18. 　Tiera MJ, Winnik FO, Fernandes JC. Synthetic and natural polycations for gene therapy: state of the art and new perspectives [J]. Curr Gene Ther， 2006; 6(1)∶59.
  19. 19. 　Li Z, Iwai M, Wu L, et al. Fluvastatin enhances the inhibitory effects of a selective AT1 receptor blocker, valsartan, on atherosclerosis [J]. Hypertension， 2004; 44(5)∶758.
  20. 20. 　Iwai M, Chen R, Li Z, et al. Deletion of angiotensin Ⅱ type 2 receptor exaggerated atherosclerosis in apolipoprotein E-null mice [J]. Circulation， 2005; 112(11)∶1636.
  21. 21. 　Hunting CB, Noort WA, Zwaginga JJ. Circulating endothelial (progenitor) cells reflect the state of the endothelium: vascular injury, repair and neovascularization [J]. Vox Sang， 2005; 88(1)∶1.
  22. 22. 　Wu Y, Zhang J, Gu Y, et al. Expansion of canine bone marrow-derived endothelial progenitor cells and dynamic observation [J]. Ann Vasc Surg， 2006; 20(3)∶387.
  23. 23. 　Montalescot G. Present and future developments of antithrombotic agents [J]. Arch Mal Coeur Vaiss， 2006; 99 Spec no.3∶17.
  24. 24. 　Cumming ME, Cumming MJ. Endovascular treatment of carotid artery stenosis [J]. J Insur Med， 2005; 37(3)∶214.
  25. 25. 　Kougias P, Lin PH, Bush RL, et al. Carotid artery stenting-current status and future directions [J]. Minerva Cardioangiol， 2006; 54(1)∶69.
  26. 26. 　Nighoghossian N, Derex L, Douek P. The vulnerable carotid artery plaque: current imaging methods and new perspectives [J]. Stroke， 2005; 36(12)∶2764.
  27. 27. 　Laroche D, Delorme S, Anderson T, et al. Computer prediction of balloon angioplasty from artery imaging [J]. Stud Health Technol Inform， 2006; 119∶293.
  28. 28. 　McWilliams RG, Fearn SJ, Harris PL, et al. Retrograde fenestration of endoluminal grafts from target vessels: feasibility, technique, and potential usage [J]. J Endovasc Ther， 2003; 10(5)∶946.
  29. 29. 　 Linsen MA, Vos AW, Diks J, et al. Fenestrated and branched endografts: assessment of proximal aortic neck fixation [J]. J Endovasc Ther， 2005; 12(6)∶647.
  30. 30. 　Kennon RE, Keggi MJ, Keggi KJ. The minimally invasive anterior approach to hip arthroplasty [J]. Orthopade， 2006; [Epub ahead of print].
  31. 31. 　Walther T, Falk V, Mohr FW. Minimally invasive surgery for valve disease [J]. Curr Probl Cardiol， 2006; 31(6)∶399.
  32. 32. 　Diethrich EB, Ghazoul M, Wheatley GH, et al. Surgical correction of ascending type a thoracic aortic dissection: simultaneous endoluminal exclusion of the arch and distal aorta [J]. J Endovasc Ther， 2005; 12(6)∶660.
  33. 33. 　Nio D, Diks J, Linsen MA, et al. Robot-assisted laparoscopic aortobifemoral bypass for aortoiliac occlusive disease: early clinical experience [J]. Eur J Vasc Endovasc Surg， 2005; 29(6)∶586(2006-06-20收稿).